Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.
Saved in:
| Title: | Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. |
|---|---|
| Authors: | Howden CW; University of Tennessee College of Medicine, Memphis, TN 38163, USA., Cook EE; Analysis Group, Inc., Boston, MA, USA., Swallow E; Analysis Group, Inc., Boston, MA, USA., Yang K; Analysis Group, Inc., New York, NY, USA., Guo H; Analysis Group, Inc., Los Angeles, CA, USA., Pelletier C; Phathom Pharmaceuticals, Florham Park, NJ, USA., Jacob R; Phathom Pharmaceuticals, Florham Park, NJ, USA., Sugano K; Jichi Medical University, Shimotsuke, Tochigi, Japan. |
| Source: | Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2023 May 02; Vol. 16, pp. 17562848231168714. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37153499 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Howden+CW%22">Howden CW</searchLink>; University of Tennessee College of Medicine, Memphis, TN 38163, USA.<br /><searchLink fieldCode="AU" term="%22Cook+EE%22">Cook EE</searchLink>; Analysis Group, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Swallow+E%22">Swallow E</searchLink>; Analysis Group, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+K%22">Yang K</searchLink>; Analysis Group, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Analysis Group, Inc., Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pelletier+C%22">Pelletier C</searchLink>; Phathom Pharmaceuticals, Florham Park, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jacob+R%22">Jacob R</searchLink>; Phathom Pharmaceuticals, Florham Park, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sugano+K%22">Sugano K</searchLink>; Jichi Medical University, Shimotsuke, Tochigi, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101478893%22">Therapeutic advances in gastroenterology</searchLink> [Therap Adv Gastroenterol] 2023 May 02; Vol. 16, pp. 17562848231168714. <i>Date of Electronic Publication: </i>2023 May 02 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101478893 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-283X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756283X%22">1756283X </searchLink><i>NLM ISO Abbreviation: </i>Therap Adv Gastroenterol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37153499 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/17562848231168714 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17562848231168714 Titles: – TitleFull: Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Howden CW – PersonEntity: Name: NameFull: Cook EE – PersonEntity: Name: NameFull: Swallow E – PersonEntity: Name: NameFull: Yang K – PersonEntity: Name: NameFull: Guo H – PersonEntity: Name: NameFull: Pelletier C – PersonEntity: Name: NameFull: Jacob R – PersonEntity: Name: NameFull: Sugano K IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2023 May 02 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1756-283X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Therapeutic advances in gastroenterology Type: main |
| ResultId | 1 |